4 stocks soaring on the ASX today

S&P/ASX 200 closes flat, but these four skyrocketed

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Who would've thought it?

After spending 99% of the day in the red, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) managed to surge at the close and finish flat at 5,904.2 led by gains in the big supermarket retailers and insurers.

Here's why these four stocks managed to soar today…

Two data security/encryption firms rocketed up today, Covata Ltd (ASX: CVT) and Senetas Corporation Limited (ASX: SEN). Covata gained 21% to 29 cents while Senetas added 13.3% to 9.4 cents. But the gains may be short-lived. Neither company released any information yesterday, but Senetas has been spruiked by an investing service (via email for free), which may be the reason why shares have shot up in both companies today.

Despite that, as data security becomes ever more important, it's likely the companies offering security technologies will be in big demand. Senetas is already profitable and is forecasting strong growth this year while Covata is a recent back-door listing, so we don't have much financial information to go on.

Genetic Technologies Limited (ASX: GTG) gained 16.3% to 5 cents, continuing the company's rollercoaster ride in the past few months. Since early January, Genetic Tech shares are up 188%, but down 42% since Feb 19, including today's rise. Clearly the market doesn't know how to value the unprofitable company, which specialises in DNA testing, including those addressing various aspects of cancer development, progression and management. Where the share price goes next is anybody's guess.

Cynata Therapeutics Ltd (ASX: CYP) also soared 16.3%, closing at $1.355. Cynata specialises in stem cell and regenerative medicine and today announced that CEO Dr Ross Macdonald would be presenting a company overview and holding one-on-one meetings with institutional investors at the annual ASX Spotlight conference in New York. If Mr Macdonald can win large US investors over, Cynata could see those investors keen to invest in the company.

Motley Fool writer/analyst Mike King doesn't own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »